AKT1 and hepatocellular carcinoma: Our results also demonstrate that, in the four Akt-inhibitor-resistant breast cancer cell lines displaying elevated SGK1 evaluated (BT-549, JIMT-1, MDA-MB-436 and HCC-1937), knockdown of SGK1 markedly suppressed cell proliferation.